Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)

Fig. 2

Disease-free and overall survival in non-randomized patients with resected high-risk stage II colon cancer. a Disease-free and b overall survival in the propensity score-matched groups. c Disease-free and d overall survival in the inverse probability of treatment weighting groups. NR-Group S (blue): surgery alone; NR-Group U (green): surgery followed by UFT/LV treatment. Abbreviations: CI, confidence interval; DFS, disease-free survival; HR, hazard ratio; NR, non-randomized; OS, overall survival; UFT/LV, uracil and tegafur plus leucovorin. P values obtained by log-rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us